Adverse events associated with COVID-19 pharmaceutical treatments
Maglione M, Klausner JD, Wirnkar PK, Fallarme I, Lak R, Sysawang K, Fu N, Yagyu S, Motala A, Tolentino D, Hempel S
Record ID 32018015531
English
Details
Project Status:
Completed
Year Published:
2024
URL for published report:
https://effectivehealthcare.ahrq.gov/products/COVID-19-pharmaceutical-treatments/rapid-research
English language abstract:
An English language summary is available
Publication Type:
Rapid Review
Country:
United States
MeSH Terms
- COVID-19
- COVID-19 Drug Treatment
- Coronavirus Infections
- SARS-CoV-2
- Antiviral Agents
- Drug-Related Side Effects and Adverse Reactions
Contact
Organisation Name:
Agency for Healthcare Research and Quality
Contact Address:
The Evidence-based Practice Center (EPC) Program, Center for Evidence and Practice Improvement, 5600 Fishers Lane, Rockville, MD 20857, USA. Tel: +1 301 427 1550
Contact Name:
The EPC Program
Contact Email:
epc@ahrq.hhs.gov
Copyright:
Agency for Healthcare Research and Quality (AHRQ)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.